MR编号 | NL/H/4438/002 | ||||||
---|---|---|---|---|---|---|---|
药品名称 | Atazanavir Lupin | ||||||
活性成分 |
| ||||||
剂型 | Capsule, hard | ||||||
上市许可持有人 | Lupin Europe GmbH Hanauer Landstrasse 139-143 60314 Frankfurt am Main Germany | ||||||
参考成员国 - 产品名称 | Netherlands (NL) Atazanavir Lupin | ||||||
互认成员国 - 产品名称 |
| ||||||
许可日期 | 2019/12/09 | ||||||
最近更新日期 | 2020/01/22 | ||||||
药物ATC编码 |
申请类型 | 附件文件下载 | 市场状态 | Withdrawn(注:已撤市) | 撤市原因:1.The company decided to withdraw the application. At the time of withdrawal, the MS considered that the data provided did not allow to conclude on a positive benefit-risk balance as major objections were raised. |